Background: The baroreflex regulates arterial blood pressure (BP). During periods when blood pressure changes, cerebral blood flow (CBF) is kept constant by cerebral autoregulation (CA). In patients with diabetes mellitus (DM), low baroreflex sensitivity (BRS) is associated with impaired CA. As sevoflurane-based anaesthesia obliterates BRS, we hypothesised that this could aggravate the already impaired CA in patients with DM resulting in a 'double-hit' on cerebral perfusion leading to increased fluctuations in blood pressure and cerebral perfusion. Methods: On the day before surgery, we measured CBF velocity (CBFV), heart rate, and BP to determine BRS and CA efficacy (CBFV mean -to-BP mean -phase lead) in 25 patients with DM and in 14 controls. During the operation, BRS and CA efficacy were determined during sevoflurane-based anaesthesia. Patients with DM were divided into a group with high BRS (DM BRS[ ) and a group with low BRS (DM BRSY ). Values presented are median (inter-quartile range). Results: Preoperative vs intraoperative BRS was 6.2 (4.5e8.5) vs 1.9 (1.1e2.5, P<0.001) ms mm Hg À1 for controls, 5.8 (4.9e7.6)
Short-term arterial blood pressure homeostasis is achieved through adjustments in autonomic nervous system activity by the arterial baroreflex. 1 Hypotension is compensated for by reflex tachycardia and peripheral vasoconstriction; conversely, acute hypertension results in vasodilation and bradycardia. Baroreflex function can be quantified by observing the HR response to a blood pressure challenge and expressed as baroreflex sensitivity (BRS). 2 In patients with diabetes mellitus (DM), BRS may be low resulting in unstable blood pressure regulation, clinically observable as resting tachycardia, exercise intolerance, 3, 4 and orthostatic hypotension. 5e7 This attenuated baroreflex function is associated with a currently unexplained increased incidence of stroke. 8, 9 This is striking, as changes in blood pressure normally do not affect cerebral perfusion because of a set of mechanisms collectively known as cerebral autoregulation (CA). 10, 11 However, when CA is impaired, cerebral blood flow (CBF) becomes dependent on blood pressure. Therefore, the association between attenuated BRS and stroke suggests that CA might be impaired in these patients as well. 12, 13 Indeed, several studies indicate that CA efficacy may be reduced early in the course of DM and suggest that autonomic and cerebrovascular regulation decline together in patients with DM. 14, 15 The relationship between BRS on the one hand and CA efficacy on the other hand in patients with DM is of particular interest during anaesthesia, because anaesthetic agents such as sevoflurane suppress autonomic nervous system activity. 16, 17 During sevoflurane-based anaesthesia, BRS is greatly reduced, 18 but CA seems unaffected in healthy subjects. 19, 20 In contrast, it is uncertain whetherdand if so howdsevoflurane based anaesthesia affects the already impaired CA in patients with DM. We hypothesised that sevoflurane-based anaesthesia could affect an already impaired CA and that this might result in a 'double-hit' on cerebral perfusion: low BRS combined with impaired CA leads to increased blood pressure fluctuations that translate unmodified into cerebral perfusion changes. To test this hypothesis, we determined BRS and CA efficacy before and during operation in patients with DM and allocated them into a group with high (DM BRS[ ) and low (DM BRSY ) BRS. A group of patients without DM served as controls.
Methods
The study was approved by the Institutional Ethics Committee of the Academic Medical Centre AMC Amsterdam (MEC 2016_116) and registered with ClinicalTrials.gov (NCT 03071432). Oral and written informed consent were obtained before inclusion.
Study population
We included patients with and without type 2 DM undergoing elective non-cardiac surgery who were willing and able to give informed consent. Exclusion criteria were laparoscopic procedures, type 1 DM, non-sinus rhythm, inability to obtain a transcranial Doppler window, Parkinson's disease, Shy-Drager syndrome, and cardiomyopathy.
Instrumentation
Continuous non-invasive, beat-to-beat arterial blood pressure measurement was obtained with a finger photoplethysmograph ( cc Nexfin, Edwards Lifesciences, Irvine, CA, USA) with the cuff placed at the middle phalanx of the middle finger of the non-dominant hand and a heart level reference device in place to correct for hydrostatic differences between the finger and the heart. 21e23 The middle cerebral artery was unilaterally insonated through the temporal window with a 2 MHz probe (Compumedics DWL Germany GmbH, Singen, Germany) attached to a headband (DWL Diamon Probe Fixation System, Compumedics DWL Germany GmbH). Insonation depth and signal gain were adjusted to an optimal signal-to-noise ratio. End tidal partial pressure of CO 2 (Pet CO2 ) was determined realtime (Normocap 200; Datex-Ohmeda, GE Healthcare, Madison, WI, USA) from side stream sampling through a nasal cannula (before operation) or tracheal tube (during operation) and displayed during the measurements. The signals of blood pressure, the envelope of CBF velocity (CBFV), CO 2 , and a marker signal were stored with a 200 Hz sample rate for offline analysis. Mean CBFV and mean blood pressure were the integral over one heartbeat; heart rate was the inverse of the inter-beat interval.
Preoperative protocol
Preoperative measurements were performed within 24 h before surgery in a temperature-controlled laboratory room at 22 C with patients resting in the semi-supine position.
Patients were instructed to breathe synchronous to a metronome at a breathing frequency of 6 bpm for three consecutive minutes in order to calculate BRS and CA efficacy (see BRS calculation and CA efficacy calculation). Pet CO2 was monitored continuously by the researcher, who instructed patients to adjust their inspiration depth and maintain normocapnia.
Intraoperative protocol
Intraoperative measurements took place before preoperative data were analysed. Anaesthesia monitoring and study instrumentation were applied at the same side used for preoperative measurements. General anaesthesia was induced i.v. with propofol, sufentanil, lidocaine, and rocuronium ( 
Cerebral autoregulation efficacy calculation
CA is a set of mechanisms that adjust cerebrovascular resistance to blood pressure changes resulting in a more or less constant CBF. 11 After a sudden change in blood pressure, CBF is restored within~5 s. 35 Given this time lag, CA effectively regulates low frequency mean blood pressure (BP mean ) oscillations (~0.1 Hz), but higher frequency oscillations (>0.15 Hz) pass unaltered into CBF oscillations. 36 Mathematically, this regulation can be described as having high-pass filter properties with a CBFV mean -to-BP mean phase lead around 0.1 Hz. Intact CA would display a phase lead around~50 at that frequency, while impaired CA is characterised by a phase lead around~30 or less. 37, 38 We recently described a novel method to quantify preoperative and intraoperative CA efficacy from augmented 0.1 Hz blood pressure oscillations using paced breathing. 20 In short, low frequency blood pressure oscillations in awake subjects originate from sympathetic nervous system modulations in blood pressure, so called Mayer waves. 39, 40 These oscillations disappear during anaesthesia, as anaesthetic agents suppress autonomic nervous system activity. 16, 20, 41 To calculate CBFV mean -to-BP mean phase lead around 0.1 Hz, sufficient amplitude of blood pressure oscillations is required. These oscillations can be created by low frequency (deep) breathing, as this modulates cardiac preload and ultimately blood pressure. We selected 2-min (120 s) episodes of artefact free data during paced breathing at 6 bpm before and during operation. Data were spline interpolated and resampled at 4 Hz. Using discrete Fourier transform, 42 we calculated power spectra for BP mean and CBFV mean , including coherence, phase difference, and gain around the 0.1 Hz frequency band. A critical coherence value >0.5 was used as cut-off to ensure that the analysis was performed on data with sufficient coherence between BP mean and CBFV mean .
Data analysis, statistics, and sample size calculation
For this study with three relatively small study groups, we did not assume normality. Therefore, patient characteristics, haemodynamics, respiratory variables, and frequency domain data are presented as median and inter-quartile range for all groups. Differences between preoperative and intraoperative values were tested using the paired Wilcoxon signed rank test. DM BRS[ and DM BRSY patients were compared with controls using Kruskal-Wallis one-way analysis of variance with post hoc DunnSid ak correction for multiple comparisons if applicable. A P-value <0.05 was considered to indicate a statistically significant difference.
The sample size calculation was performed to be able to detect previously described differences in CA efficacy and BRS. For CA efficacy, the study by Kim patients per group (total sample size 45), allowing for a 20% drop-out rate.
Results

Patient characteristics, baroreflex sensitivity and group allocation
A total of 46 patients were included in the study. Seven patients were excluded, two because of insufficient adherence to the protocol before operation; two because of non-sinus rhythm; and three patients because no transcranial Doppler window was obtained. ], respectively (see Fig. 3 ).
Haemodynamics and respiratory variables
In all groups, anaesthesia tended to decrease blood pressure and heart rate, while CBFV and Pet CO2 did not change. 
Discussion
This study tested preoperative and intraoperative CA efficacy in patients with DM and a control group of patients without DM. Patients with DM were divided into a group with high preoperative BRS and a group with low preoperative BRS. As expected, the group with lower BRS also had an impaired CA efficacy, while the high BRS group had similar CA efficacy to controls. 14, 15 Sevoflurane based anaesthesia virtually obliterated BRS across all groups but did not affect CA, irrespective of preoperative CA status. Therefore, we reject the hypothesis that sevoflurane-based anaesthesia contributes to a 'double- hit' phenomenon on cerebral perfusion in patients with DM. We could not confirm additional impairment of CA in patients with DM during anaesthesia. However, we emphasise that patients with low BRS and impaired CA are still at risk for cerebral hypoperfusion as a consequence of two failing physiological systems.
Integrity of CA during general anaesthesia is not selfevident. From as early as 1970, reports have come out that general anaesthetics such as cyclopropane impair CA 43 and more recently, others have found that desflurane 44 and isoflurane 44, 45 suppress CA efficacy to a greater extent than propofol. Generally, it has been established that volatile anaesthetics have more cerebrovascular dilating properties than i.v. agents 46 and hence have more potential to interfere with CA. Studies testing the effects of sevoflurane-based anaesthesia on CA mostly quantified CA efficacy only during operation 47, 48 and omitted measurements taken before operation. These studies were thus unable to examine if changes in CA were elicited by sevoflurane-based anaesthesia. To our knowledge, only one study, 19 and one of our previous papers, 20 tested preoperative and intraoperative healthy subjects and found that sevoflurane-based anaesthesia did not interfere with normal CA efficacy. The present study focussed on testing the effects of sevoflurane-based anaesthesia in patients with an already impaired preoperative CA efficacy. To obtain these patients, we chose to include patients with DM and reduced autonomic function (low BRS) as a study group, as these patients are at risk for impaired CA. 14,15 Indeed, we found lower CA efficacy indices in the patients with DM that had lower BRS. Primarily, we were concerned that sevoflurane based anaesthesia might impair CA efficacy further if it was already impaired before operation, resulting in a 'double-hit' on cerebral perfusion where more severe blood pressure variations attributable to low BRS lead to more severe changes in CBF as a result of less effective CA. We found that sevofluranebased anaesthesia resulted in low BRS in all patients, but CA remained unaffected at preoperative values. Therefore, we reject the hypothesis that sevoflurane-based anaesthesia contributes to a 'double-hit' phenomenon on cerebral perfusion in patients with DM. The fact that intraoperative BRS was low across all groups confirms earlier evidence. 18, 34 Anaesthetic agents suppress autonomic nervous system activity 16 and BRS, even in healthy subjects. In other words, anaesthesia induces some form of autonomic dysfunction. When patients displayed impaired autonomic function already before operation (in the DM BRSY group), we found no additional reduction of BRS during operation. We hypothesise that if HR before operation does not respond to changes in BP sys attributable to autonomic dysfunction, intraoperative values will be similar.
Limitations
First, patients in this study were allocated into groups based on BRS. We calculated BRS non-invasively using linear regression on paced breathing data. However, gold standard BRS calculation is performed using the Oxford method with i.v. phenylephrine or nitroprusside. 2 Using this method, Tanaka and Nishikawa 18 reported that BRS decreased from 22.5 to 6.2 (À72%) ms mmHg À1 after induction of anaesthesia in healthy young controls, whereas this was 6.2 vs 1.9 (À69%) ms mm Hg À1 in our study. A possible explanation for this difference could be the (lower) age in the Tanaka-study compared with our study population. Also, it seems that absolute values for BRS are difficult to compare between different methods, but that relative values follow a similar trend. Second, we used a recently published method to assess CA efficacy before and during anaesthesia. 20 This method uses completely non-invasive measurement techniques and interventions. In short, blood pressure was measured using cc Nexfin, a device validated in anaesthetised patients across a wide range of blood pressure values. 21 CBFV measurements were conducted using transcranial Doppler ultrasound and CBFV changes were assumed to reflect changes in CBF. It has been shown that changes in CBFV parallel changes in CBF during hypercapnia. 49, 50 Furthermore, an earlier study found that CA quantification was similar when non-invasive blood pressure measurement techniques were adopted instead of invasive measurement techniques. 51 Third, unnatural (low) breathing frequencies as imposed during our measurements could influence CA quantification, especially as changing arterial CO 2 partial pressures strongly influence CA integrity. A major concern during the preoperative measurements was therefore to instruct patients carefully to maintain normocapnia by adjusting their tidal volumes. Changes in Pet CO2 might have influenced individual measurements and this could be an explanation for the (sometimes significant) individual preoperative vs intraoperative differences displayed in Fig. 4 . However, Pet CO2 on average did not differ across all study groups, and we do not think this has influenced the aggregated results.
Fourth, we unexpectedly found no differences in either BRS or CA efficacy between controls and patients with DM who had high BRS before operation. Also, CA efficacy in the control group was slightly below what we expected from a healthy population. In a previous study, mean CBFV mean -to-BP mean phase lead as a measure for CA efficacy was~50 vs~40 vs~30 in controls vs DM without complications vs DM with complications. 15 We found a phase lead of 43 (inter-quartile range 38e46) in our control group. We are inclined to think that these patients, all undergoing elective surgery, may differ from previously described healthy controls. However, this does not influence the main findings that patients with attenuated BRS displayed impaired CA efficacy and that sevoflurane-based anaesthesia did not influence this. Lastly, the study aimed to investigate the interaction between low BRS and impaired CA efficacy before and during anaesthesia (the 'double-hit hypothesis'). We used patients with DM as a model to investigate this because previous evidence indicated that these patients were possibly at risk for impaired BRS, CA, or both. 14, 15 Because patients with DM were divided into two groups based on BRS (low vs high), this resulted in two otherwise heterogeneous groups of patients with different length of diabetes history or associated complications. The division of patients with DM based on BRS, therefore, has disadvantages. BRS is not routinely measured and as it turns out, the two groups with high and low BRS did not differ based on clinical parameters such as age, weight, length, haemoglobin A1c, fasting glucose, or DM complications. This could be a limitation when translating the results from the present study into a clinical setting.
Conclusion
CA efficacy was impaired before operation in patients with diabetes who also had low BRS. Additionally, CA is unaffected by sevoflurane-based anaesthesia, irrespective of preoperative status. Therefore, we reject the hypothesis that sevofluranebased anaesthesia contributes to a 'double-hit' phenomenon on cerebral perfusion in patients with DM. Cerebral autoregulation in patients with type 2 diabetes -1305
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